About Protein CC2D2B
Protein CC2D2B (CC2D2B) is a protein
from Homo sapiens identified by UniProt accession
Q6DHV5, 1437 residues long.
MolForge cross-references it against 0 known binders and
20 disease associations.
Target properties
| Protein name | Protein CC2D2B |
| UniProt accession | Q6DHV5 |
| Gene | CC2D2B |
| Organism | Homo sapiens |
| Length | 1437 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (20)
Diseases linked to this target (Open Targets).
- lymphocyte count · score 0.42
- blood protein measurement · score 0.16
- total blood protein measurement · score 0.15
- mean corpuscular volume · score 0.14
- age at menopause · score 0.14
- platelet count · score 0.11
- BMI-adjusted waist circumference · score 0.09
- red blood cell density measurement · score 0.09
- body height · score 0.07
- aortic measurement · score 0.05
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q6DHV5-F1 | alphafold | PREDICTED | 68.12 | — |
Amino-acid sequence (1437 residues)
MKKSQREDIF KKMSEEMDNI TAEEIIDKHL QKDLDAEENQ NVAKTLRGKV REKLKISKIN KGEKSSTEQL IDSEIHQRSK LSPQTEVSLD ESLSFFILSG EEGSALGKSS EQRPVNRSYP KCFSLGVNLQ NVAESEEEEF MKEFILTDIL KVKAADYEDD QEQIKKQKAN IFVPSSSPVV NQRKLPKDMM PRILEDEGFY IQRKPEIYKK TCNKMENRLL KLEEGKCWFG ESGEIMSLPT PIKQSWNFRL NVRKEPLNPL LKTIYRKAVK YDLGSSFMNK MEGSREIYQL DLNIVGLQFS HHHLFNQEQV LCARLLQLYE CFQDRQQQNV SQLLYEKLKA LTDATKLSNE NSEINQLTRK SLQDYYWQIS NTKQMYDLER GKDLSLLHSI LRTWKQIKSL RHGQGFTSTP IKLQVQRIKM NKCDEQEQIS EMSETEKKNE GKELKNGKKL ESLSYLASDE TEIERIKPIT LRPQLSFTAE LTSLSKCSLH EQKRRAKIQK LKYFIKIFYN NKQVSCTSVS PLQFDFKVMF QQIFNIQLMY WPEVICLEVY EKSKRTSLLA KLYIPLPNYT ELKGKTALQY VEFSSDKLVM PADGEVGSNV PFLLEGNGTE ELCLLTSGKL SYSLSWSLDE NGLPLIPMPQ SLRSSYCSML RNVDARSVPG IPWLMNEQKL FEWANEVRID PNNPEYSDLM ESVTYMRLKG QDIPKYFRLE QLQDEFNFVS EEEMAKSKRF QLLQLRNAGQ LDNFLLQQMP LHDTEIPDLV FQEYESQKEK EVSVSDVNSI TAQRINSANF LKKVRRLIMK RIVKISKCNL SDIVNDYEEI VSTSQLTDAV CKFVEPRRKL KPQRKERKKV TAQAISDGDI KILVRIVRAY NIPTRKTTIN GSLDMPTCLK SSISCLRHRE TIKSVASDET LHEDTVHPFV EVSFQHTVYK TNTASGSHPC WNEEIKVDFV SPGHDYSFSS LSKIKDNIYI NIFDEMMTEK HEDHCLKSCS GHSYIRKNWL GCIVFPFSAL LQQSEISGTF QVTIPPVLLG YTWSNTYVFP KEDSNEQNLK ECTFLNIFAT IEPQISYVTC NPTLDKFLDQ TEVLQRAQIF KKNCKAMFPN RRIVTTVFND EGIQFLVTRY IKALNPPQQL LDIFLHNSNA TFDLIARFVS LIPFVPNTPD ENDGSDIWMT SEHCISLAIG NKEEHAILLC NFFLYFGKKA LVLLGTSVLE GHVAYVVTQE TNEYLLWNPS TGQCYKQFDP FCPLKSVDCL FDDRNVWFNI QQNNTPMAVF FDYSKESFWK QLLPKNVQGT KIQSIQPEEI IYFETDKSMV EDLRNRIERT LKSKVMEWRP KHPTHWNRQC TFILRQILPK LEFGIGSFVS SEGDNEFERI LQFYWVTGFP IQMPYIDVQS IIDAVYQTGI HSAEFPQTEF ALAVYIHPYP NNILSVWVYL ASLVQHQ
Explore Protein CC2D2B with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets